INBP 8-K 2026-09-25
INTEGRATED BIOPHARMA INC (INBP) 8-K dated 2026-09-25 — accession 0001437749-26-031247.
INTEGRATED BIOPHARMA INC (INBP) is a packaged foods company listed on US.
INBP: SECURITIES AND EXCHANGE COMMISSION
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported INBP revenue for 2026-06-30 was $43.9M. Net income was -$2.8M. Revenue was down 19.3% from 2025-06-30 to 2026-06-30. INBP currently screens at market cap $5.6M.
Not investment advice. The INBP SEC hub lists recent forms. The stock page is the research view.